PT Central Proteina Prima Tbk

IDX:CPRO.JK

50 (IDR) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) IDR.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 9,027,2768,242,3438,028,0787,573,5067,175,7647,390,5806,575,5708,597,2088,975,0649,454,6617,677,8236,835,8137,529,4396,243,8766,832,7548,169,9286,123,044
Cost of Revenue 7,349,0776,597,6406,533,1736,228,0035,834,0646,155,9485,414,6797,174,2547,513,8367,996,8946,532,9535,870,0406,835,7615,584,2045,996,6386,626,0495,023,130
Gross Profit 1,678,1991,644,7031,494,9051,345,5031,341,7001,234,6321,160,8911,422,9541,461,2281,457,7671,144,870965,773693,678659,672836,1161,543,8791,099,914
Gross Profit Ratio 0.1860.20.1860.1780.1870.1670.1770.1660.1630.1540.1490.1410.0920.1060.1220.1890.18
Reseach & Development Expenses 000000000002,20300000
General & Administrative Expenses 160,147146,888123,928100,351120,964137,625133,549176,769226,157224,396198,990107,171520,083539,637576,570538,504386,639
Selling & Marketing Expenses 255,808250,005201,776134,986261,638245,298206,235258,885291,531268,009199,383183,367448,193470,617449,312412,538253,439
SG&A 880,621396,893325,704235,337382,602382,923339,784435,654517,688492,405398,373290,538968,2761,010,2541,025,882951,042640,078
Other Expenses 83,356407,821355,795448,811428,174-183,959-1,044,950-215,880-179,220-220,346023,2690-180,655-121,929-27,31095,194
Operating Expenses 963,977804,714681,499684,148810,776827,4891,132,6261,383,9911,247,0681,079,6491,224,787974,0331,074,4291,010,2541,025,882951,042640,078
Operating Income 714,222805,564821,783618,321165,480352,700-1,031,979-1,155,48818,342166,698-794,415-270,734-2,234,387-350,582-189,766592,837459,836
Operating Income Ratio 0.0790.0980.1020.0820.0230.048-0.157-0.1340.0020.018-0.103-0.04-0.297-0.056-0.0280.0730.075
Total Other Income Expenses Net -191,659-328,8851,464,975-422,930-750,9731,479,170-1,480,200-569,914-892,486-538,9141,751,378-492,747-1,959,789-380,803-14,013-1,099,279-32,327
Income Before Tax 522,563476,6792,286,758195,391-350,1491,831,870-2,512,179-1,725,402-874,144-372,216956,963-353,184-2,234,387-731,385-203,779-506,442427,509
Income Before Tax Ratio 0.0580.0580.2850.026-0.0490.248-0.382-0.201-0.097-0.0390.125-0.052-0.297-0.117-0.03-0.0620.07
Income Tax Expense 120,789102,70174,465-186,031-1,286109,166127,241271,636328,28717,691-241,07482,797-198,184-95,77113,376-99,75168,729
Net Income 401,468373,6682,208,722380,902-348,8631,722,582-2,636,278-1,987,884-1,200,383-389,4101,200,315-435,894-2,036,125-635,482-217,171-407,182358,413
Net Income Ratio 0.0440.0450.2750.05-0.0490.233-0.401-0.231-0.134-0.0410.156-0.064-0.27-0.102-0.032-0.050.059
EPS 6.746.337.16.4-5.8634.03-65.14-49.12-29.66-9.6229.7-10.77-50.31-15.7-5.39-19.4520
EPS Diluted 6.746.337.16.4-5.8634.03-65.14-49.12-29.66-9.6229.7-10.77-50.31-15.7-5.16-19.4514
EBITDA 884,496851,3102,694,370737,642632,5582,545,661-823,874-867,733-70,979154,936-571,48198,829-1,574,523-391,720-187,673592,837134,278
EBITDA Ratio 0.0980.0940.1060.090.029-0.012-0.147-0.005-0.020.016-0.074-0.0170.14-0.063-0.0270.0730.022